Josa-Cullere, Laia; Madden, Katrina S.; Cogswell, Thomas J.; Jackson, Thomas R.; Carter, Tom S.; Zhang, Douzi; Trevitt, Graham; Davies, Stephen G.; Vyas, Paresh; Wynne, Graham M.; Milne, Thomas A.; Russell, Angela J. published the artcile< A Phenotypic Screen Identifies a Compound Series That Induces Differentiation of Acute Myeloid Leukemia Cells In Vitro and Shows Antitumor Effects In Vivo>, Quality Control of 112-63-0, the main research area is imidazopyridine antitumor acute myeloid leukemia cell differentiation human.
Induction of differentiation is a promising therapeutic strategy against acute myeloid leukemia. However, current differentiation therapies are effective only to specific patient populations. To identify novel differentiation agents with wider efficacy, authors developed a phenotypic high-throughput screen with a range of genetically diverse cell lines. From the resulting hits, one chem. scaffold was optimized in terms of activity and physicochem. properties to yield OXS007417 I, a proof-of-concept tool compound, which was also able to decrease tumor volume in a murine in vivo xenograft model.
Journal of Medicinal Chemistry published new progress about Acute myeloid leukemia. 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Quality Control of 112-63-0.
Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics